Rep. Daniel Meuser

Maddy summaryThis bill directs the Architect of the Capitol to create a time capsule for the U.S. Semiquincentennial (250th anniversary of independence). Congressional leadership will determine its contents, including representative materials about the Semiquincentennial, copies of key legislative milestones, and a message to future Congress. The capsule will be sealed on the Capitol's West Lawn by July 4, 2026, and remain unopened until July 4, 2276, when it will be presented to the 244th Congress for their consideration. The bill is procedural and does not affect citizens or change existing laws.

Maddy summaryThe Revoke Iranian Funding Act of 2023 would cancel all existing U.S. licenses and exemptions allowing funds to be released to Iran for humanitarian purposes, including a $6 billion transfer from South Korea. It also rescinds a specific waiver issued in September 2023 that permitted such transfers. The bill requires the Treasury to submit a 30-day report to Congress detailing Iranian assets blocked by the U.S. and current sanctions exemptions related to Iran. This legislation directly restricts U.S. financial access for Iran and its designated entities, aiming to prevent funds from being diverted to support terrorism.

Maddy summaryThis bill, titled "Freezing HAMAS Act" (though it concerns Iran sanctions, not Hamas), reinstates U.S. sanctions on Iran that were previously waived or suspended under agreements with Iran. It specifically targets sanctions from the 2012 Iran Freedom and Counter-Proliferation Act and the 2012 National Defense Authorization Act, including a September 2023 waiver related to fund transfers. The bill prohibits the U.S. government from releasing funds or assets to Iran or granting further waivers related to these sanctions. It directly affects U.S. government actions regarding Iran financial transactions and enforcement of existing sanctions.

Maddy summaryThis bill, HR 5796, prohibits the Department of Health and Human Services from implementing a proposed rule requiring minimum staffing levels in nursing homes. It creates an advisory panel of 15 members - including rural nursing home staff and experts - to study workforce shortages and report on access barriers for seniors, especially in rural areas. The panel must submit an initial report within 60 days, analyzing staffing challenges and recommending solutions to strengthen the nursing home workforce. These provisions directly aim to prevent nursing home closures (like the 129 that occurred in 2022) that threaten rural seniors’ access to care.

Maddy summaryHR 5614 extends duty-free treatment for Haitian apparel imports under the Caribbean Basin Economic Recovery Act until September 30, 2035. It modifies the quantitative limit for eligible apparel imports to cap at 1.25% of the U.S. market for the most recent 12-month period, replacing the previous fixed annual period structure. This bill directly affects Haitian apparel exporters and U.S. importers of Haitian-made clothing by maintaining tariff preferences. The extension also requires the President to adjust the Harmonized Tariff Schedule to restore lost benefits for eligible items affected by prior tariff schedule changes.

Maddy summaryThe DRA of 2023 adjusts Medicare payment rates for specific durable medical equipment (DME) items that were part of the 2021 competitive bidding program but for which no supplier contracts were finalized. It directly affects DME suppliers and Medicare beneficiaries by establishing a new 2024 payment formula: 90% of the adjusted payment amount plus 10% of the unadjusted fee schedule for eligible items. The bill also extends a temporary transition rule for non-rural areas through December 31, 2024, while delaying a regulatory change until 2025. These provisions aim to stabilize payments for DME items that did not transition to standard pricing under prior rules.

Maddy summaryThe Maintaining Investments in New Innovation Act (HR 5547) extends the exclusivity period for certain advanced drugs from 7 to 11 years. It defines an "advanced drug product" as a drug using genetically targeted technology to change how genes work, such as drugs that suppress or activate gene function. The bill amends the Social Security Act to update the definition of "qualifying single source drug" to include these advanced therapies with the longer exclusivity period. This change directly affects drug manufacturers developing such advanced therapies and influences Medicare's drug coverage rules by delaying generic competition for these specific treatments.

Maddy summaryHR 5371, the Choices for Increased Mobility Act of 2023, updates Medicare payment rules for manual wheelchairs. It clarifies that Medicare Part B will not cover the extra cost of titanium or carbon fiber materials in a wheelchair's base, effective January 1, 2023. This specifically affects Medicare beneficiaries who use manual wheelchairs with these materials, as payments will now be calculated without including those component costs. The bill directly changes how Medicare reimburses providers for such wheelchairs by excluding these materials from the standard payment amount. This is a technical adjustment to Medicare's fee schedule, not a new benefit or eligibility change.

Maddy summaryThis bill changes Medicare payment rules for anesthesiologist services in specific rural hospitals. It requires Medicare to pay for anesthesiologist services in qualifying rural hospitals using the same "reasonable cost, pass-through" reimbursement method currently used for certified registered nurse anesthetists (CRNAs), rather than the standard physician payment rate. The bill directly affects rural hospitals and anesthesiologists working in those facilities, ensuring they receive comparable reimbursement to CRNAs under existing rules. The change applies to services provided during cost reporting periods starting after the bill's enactment date. This is a technical adjustment to payment methodology, not a new coverage benefit.

Maddy summaryThis bill changes how Medicare counts hospital stays for coverage of skilled nursing care. It treats time spent in outpatient observation (not admitted as an inpatient) as part of the required 3-day inpatient hospital stay. This means beneficiaries who received outpatient observation services will have that time counted toward the 3-day requirement, potentially making them eligible for skilled nursing facility coverage they might otherwise have lost. The change applies to services beginning January 1, 2024, with limited retroactive appeal options for services completed before the law's enactment. It directly affects Medicare beneficiaries needing skilled nursing care after hospital treatment.